Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the full record of transactions filed by Walsh Colin. Director active across 1 company, notably Attovia Therapeutics, Inc.. Cumulatively, 27 disclosures have been recorded. Breakdown: 2 buys · 23 sells. Total volume traded: €10.9m. Activity tracked since 6 August 2026. The latest transaction was disclosed on 5 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Walsh Colin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.